Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015
Open Access
- 10 December 2015
- journal article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
Abstract
Evidence of current and past Middle East respiratory syndrome coronavirus (MERS-CoV) infection in dromedary camels slaughtered at an abattoir in Kano, Nigeria in January 2015, was sought by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and serology. MERS-CoV RNA was detected in 14 (11%) of 132 nasal swabs and antibody in 126 (96%) of 131 serum samples. Phylogenetic analyses demonstrate that the viruses in Nigeria are genetically distinct from those reported in the Arabian peninsula.Keywords
This publication has 7 references indexed in Scilit:
- Reliable typing of MERS-CoV variants with a small genome fragmentJournal of Clinical Virology, 2015
- Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo studyThe Lancet Respiratory Medicine, 2014
- Geographic Distribution of MERS Coronavirus among Dromedary Camels, AfricaEmerging Infectious Diseases, 2014
- MERS Coronaviruses in Dromedary Camels, EgyptEmerging Infectious Diseases, 2014
- Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigationPublished by Elsevier ,2013
- Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013Eurosurveillance, 2013
- Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological studyPublished by Elsevier ,2013